80336 München, de
+49(89) 599 766 0
Pfizer Inks Global License to Genomatix Software and Databases
"Adding Genomatix to Pfizer's existing genomics software capabilities was a natural choice." said Peter Grant, CEO of Genomatix Software, Inc. "Our broad set of capabilities are a good compliment to those that Pfizer already has in house. We are pleased to be a part of Pfizer's significant effort in molecular genomics. We believe our tools will provide a great value to their research effort, but the proof is always in the results. Now the fun really begins!" he concluded.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to email@example.com.